1. Medicines
  2. Haematology
  3. REVOLADE® (eltrombopag olamine)
  4. Contact us

Prescribing information

 

Speak to a Novartis representative

Please complete this form to be contacted by a Novartis promotional representative in your area. For medical information, please contact our Medical Information team by email. Fields marked * below are mandatory.

Your information will be used to put you in contact with a Novartis representative and handled in accordance with our Privacy Notice.

HCP19-C002(1)a June 2020

For more information, refer to the REVOLADE® (eltrombopag olamine) Summary of Product Characteristics: https://www.medicines.org.uk/emc/product/7819/smpc

Legal Category: POM.

Aluminium blisters (PA/Alu/PVC/Alu) in a carton containing 14 or 28 film-coated tablets and multipacks containing 84 (3 packs of 28) film-coated tablets. Marketing Authorisation (MA) number, quantities and NHS price: EU/1/10/612/002 – 25 mg x 28 tablet pack £770, EU/1/10/612/005 – 50 mg x 28 tablet pack £1540, EU/1/10/612/008 – 75 mg x 28 tablet pack £2310

 

×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at http://www.report.novartis.com/
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]